NCT04276623View on ClinicalTrials.gov

Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment

RecruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

February 25, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Atopic Dermatitis

Trial Locations (1)

3584CX

RECRUITING

University Medical Center Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

UMC Utrecht

OTHER